Related Experiment Video
Updated: Jul 11, 2026
08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
Obstetric management of thyroid disease
Mumtaz Rashid1, Mohammed H Rashid
1Department of Obstetrics and Gynaecology, James Paget University Hospital, Gorleston, Great Yarmouth, Norfolk, NR31 6LA, United Kingdom. mumtaz.rashid@jpaget.nhs.uk
Obstetrical & Gynecological Survey
|September 18, 2007
Summary
Maternal thyroid disorders during pregnancy require timely treatment to prevent adverse outcomes. Screening for thyroid dysfunction, even mild cases, is crucial for fetal neurodevelopment and maternal health.
Area of Science:
- Endocrinology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Thyroid gland physiology significantly changes during pregnancy.
- Thyroid hormone levels are gestational-age dependent.
- Accurate interpretation of thyroid hormone levels is vital for preventing pregnancy complications.
Purpose of the Study:
- Highlight the importance of timely thyroid disease treatment in pregnancy.
- Emphasize the need for screening subclinical hypothyroidism.
- Discuss the role of thyroid hormone levels in fetal neurodevelopment and postpartum thyroiditis.
Main Methods:
- Measurement of serum thyroid stimulating hormone (TSH) and free thyroxine.
- Utilizing gestation-age-specific TSH thresholds for diagnosis.
- Assessing thyroid peroxidase antibody (TPO Ab) and thyroglobulin autoantibody (TgAb) for postpartum thyroiditis prediction.
Main Results:
- Subclinical hypothyroidism can impact fetal neurodevelopment.
- Gestational iodine deficiency remains a concern in some regions.
- Thyroid peroxidase antibody and thyroglobulin autoantibody accurately predict postpartum thyroiditis.
Conclusions:
- Early diagnosis and treatment of maternal thyroid dysfunction are essential for positive maternal and fetal outcomes.
- Development of pregnancy-specific free thyroxine thresholds is needed.
- Large-scale trials are required to evaluate preconception and early pregnancy screening for thyroid disorders.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...